The First Microbes That Shape a Lifetime: A Glimpse into Targeted Probiotics for Infant Health

Long before a child takes their first steps or speaks their first words, another critical system is quietly developing inside their body: the gut microbiome. In the earliest months of life, the microbes that colonize an infant’s gut help shape digestion, metabolism, immune development, and long-term health. Disruptions to this early microbial ecosystem have been linked to conditions ranging from allergies and asthma to metabolic disorders later in life.

So, parents, clinicians, and researchers alike have started to ask: Can we guide the development of a healthy microbiome from the very beginning of a child’s life?

Unfortunately, the reality is that it’s not as simple as adding a probiotic to a bottle of formula. The infant gut is not an empty vessel waiting to be filled with “good bacteria.” It’s a complex ecosystem shaped by diet, existing microbial communities from the surrounding environment, and their countless interactions. For instance: A probiotic strain might thrive in one infant’s developing microbiome but struggle in another’s, and certain dietary sugars might feed beneficial microbes in one context while remaining entirely unused in another. Understanding these interactions between probiotics, nutrients, and the microbiome is one of the most important challenges in microbiome research today.

A recent study published in Microorganisms titled, “In Vitro Probiotic Modulation of Specific Dietary Complex Sugar Consumption in Fecal Cultures in Infants,” attempts to tackle this challenge by exploring how probiotics influence the way infant microbiomes metabolize dietary carbohydrates. This work offers an intriguing glimpse into how scientists may one day design targeted probiotic and synbiotic strategies for infant nutrition.

Turning the Gut Microbiome into a Live Metabolic Experiment

The researchers – led by Daniela Mollova, Ph.D. from the Centre of Technologies at Paisii Hilendarski University of Plovdiv in Bulgaria – set out to answer the question: How does an infant’s gut microbiome metabolize various dietary carbohydrates, and how does introducing a probiotic affect that? To explore this, they turned to Biolog’s PreBioM™ plates.

PreBioM plates allow researchers to test how microbes (either single strains or mixed community samples) utilize dozens of prebiotic substrates in a single experiment. Each well in these three specialized 96-well microplates contains a different carbon substrate — ranging from simple sugars to complex fibers and food extracts – totaling up to 90 different substrates (as well as control wells). If the microbes can successfully metabolize the substrate in a well, they grow and that growth can be measured as an increase in optical density in that well. On the other hand, if the microbes are unable to metabolize the substrate, then no or low growth is observed.

PreBioM3 plate – PB-M3 Fiber/food extract prebiotic substrate utilization assay

Plate map depicting the ~90 carbon sources included in PreBioM3, one of three assays in the PreBioM series alongside PreBioM1 and PreBioM2.

The research team collected fecal microbiome samples from three donors:

• Two infants
• One adult

In this study, the researchers set up three experimental conditions:

• Microbiome alone
• Probiotic alone (Bifidobacterium bifidum)
• Microbiome co-cultured with the probiotic

They then inoculated these cultures onto the PreBioM plates, incubated them for 24 hours, and observed how the microbial communities responded when exposed to different carbon substrates.

What The Researchers Uncovered

Within one day, researchers could see which carbon substrates each microbial community could metabolize and how the probiotic altered that activity.

Consolidated data from the original publication Tables 1, 2, and 3.

One of the clearest patterns was a difference between infant and adult microbiomes. The adult microbiome showed broader metabolic capabilities, utilizing a wider range of substrates (27 of the ~90 substrates tested) than the infant fecal microbiomes (just 15). That’s not surprising, as adult microbiomes are more diverse and metabolically mature than those of infants.

The probiotic alone showed growth on 8 substrates, showing an even more limited metabolic range than the infant fecal microbiomes. This suggests that B. bifidum can’t thrive on most nutrients alone and may depend highly on its environment and other microbes.

The most interesting observation came from adding the probiotic to the infant microbiome samples. Co-culture (microbiome + probiotic) showed growth on several substrates including enhanced growth – greater than that observed with probiotic alone or microbiome alone – for a few of the substrates (e.g. Maize flour). In other words, interactions between B. bifidum and the infant microbiome enhanced their ability to utilize substrates that neither could process as well on their own. This suggests that probiotics may do more than simply “add beneficial bacteria”; they can also reshape how the existing microbiome processes nutrients through cross-feeding and other beneficial interactions.

Why This Matters for Probiotic Development

These findings highlight a critical point: The effectiveness of a probiotic often depends on the nutritional and microbial environments in which it operates. In other words, probiotics and prebiotics don’t act independently, they interact. This is the foundation of synbiotic design, where specific probiotic strains are paired with substrates that support their metabolic activity (and sometimes even packed into multi-strain consortia).

The challenge, historically, has been figuring out which combinations actually work. Functional phenotyping tools like Biolog’s PreBioM plates – combined with the Odin system for automated incubation and measurement of up to 50 plates simultaneously – offer a practical solution. Instead of guessing which prebiotic fibers might support a probiotic strain, researchers can combine a probiotic with a microbiome sample and screen dozens of potential substrates simultaneously. What once required months of separate experiments can now happen in a single high-throughput screening workflow.